Dirk J. de Jong - Concepedia

Author

Dirk J. de Jong

Also Known As

A. Van Esch, D J de Jong, D W Hommes, D de Jong, D. J DE JONG, D. J. De Jong, D. J. de Jong, D.J. De Jong, D.J. Jong, D.J. de Jong

214

Publications

7.9K

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Radboud University Medical Center University Medical Center Groningen Amsterdam UMC Location University of Amsterdam University Medical Center Utrecht

About

Dirk J. de Jong is an author at Radboud University Nijmegen specializing in medicine, gastroenterology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	18	1.3K
2	Public Health	2	2	139
3	Allergy	2	2	87
4	Cell Biology	2	2	407
5	Biochemistry	1	1	14

Dirk J. de Jong

Publications

7.3K

Citations

H-Index

Page 1

	Year	Citations
Genome-wide association identifies multiple ulcerative colitis susceptibility loci Dermot McGovern, Agnès Gardet, Leif Törkvist, Nature Genetics Genome-wide Association StudyGenome-wide Association IdentifiesImmunologyGenetic EpidemiologyUlcerative Colitis	2010	674
Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study Mirthe E. van der Valk, Marie‐Josée J. Mangen, Max Leenders, Gut	2012	491
NOD2 and Toll-Like Receptors Are Nonredundant Recognition Systems of Mycobacterium tuberculosis Gerben Ferwerda, Stephen E. Girardin, Bart Jan Kullberg, PLoS Pathogens InflammationToll-like ReceptorsHuman Tlr2Pulmonary TuberculosisMedical Microbiology	2005	359
Nucleotide-Binding Oligomerization Domain-2 Modulates Specific TLR Pathways for the Induction of Cytokine Release Mihai G. Netea, Gerben Ferwerda, Dirk J. de Jong, The Journal of Immunology	2005	269
High frequency of early colorectal cancer in inflammatory bowel disease Maurice Lutgens, Frank P. Vleggaar, M.E.I. Schipper, Gut	2008	224
<i>NOD2</i> mediates anti‐inflammatory signals induced by TLR2 ligands: implications for Crohn's disease Mihai G. Netea, Bart Jan Kullberg, Dirk J. de Jong, European Journal of Immunology	2004	214
Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease Marieke J. H. Coenen, Dirk J. de Jong, Corine J. van Marrewijk, Gastroenterology InflammationAutoimmune DiseaseHematologyGastroenterologyImmunology	2015	193
Molecular prediction of disease risk and severity in a large Dutch Crohn’s disease cohort Rinse K. Weersma, Pieter Stokkers, Adriaan A. van Bodegraven, Gut	2008	183
Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2 Theo S. Plantinga, Tania O. Crișan, Marije Oosting, Gut	2011	183
Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease Bindia Jharap, Nanne K.H. de Boer, Pieter Stokkers, Gut	2013	140

Page 1